KR910020015A - 비-라세미형의 푸로[3,4-c] 피리딘 유도체의 제조방법 - Google Patents

비-라세미형의 푸로[3,4-c] 피리딘 유도체의 제조방법 Download PDF

Info

Publication number
KR910020015A
KR910020015A KR1019910007684A KR910007684A KR910020015A KR 910020015 A KR910020015 A KR 910020015A KR 1019910007684 A KR1019910007684 A KR 1019910007684A KR 910007684 A KR910007684 A KR 910007684A KR 910020015 A KR910020015 A KR 910020015A
Authority
KR
South Korea
Prior art keywords
group
hydrogen
alkyl
carbon atoms
alkoxy
Prior art date
Application number
KR1019910007684A
Other languages
English (en)
Inventor
알. 에크 챨스
씨. 아렌스 폴
마리 솔쯔스타인 르
Original Assignee
게라르 보푸르
소시에떼 드 꽁세이으 드 르셰르셰에 다쁠라까시옹 시앙띠피끄(에스.세.에흐.아.에스)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 게라르 보푸르, 소시에떼 드 꽁세이으 드 르셰르셰에 다쁠라까시옹 시앙띠피끄(에스.세.에흐.아.에스) filed Critical 게라르 보푸르
Publication of KR910020015A publication Critical patent/KR910020015A/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/06—Peri-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/182—Heterocyclic compounds containing nitrogen atoms as the only ring heteroatoms in the condensed system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P41/00—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
    • C12P41/003—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions
    • C12P41/004—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions by esterification of alcohol- or thiol groups in the enantiomers or the inverse reaction

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

내용 없음

Description

비-라세미 형의 푸로[3,4,-C] 피리딘 유도체의 제조 방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (8)

  1. 하기 일반식(2) 또는 (3)의 화합물등 중에서 선택된 1종의 라세미 혼합물을, 이 화합물의 (+) 또는 (-) 거울상 이성질체 형을 가수분해시킬 수 있는 에스테라제와 작용시킨 다음, 가수분해되지 않은 화합물과 가수분해된 화합물을 분리시킴으로써 분할하는 것을 특징으로 하는, 실질적으로 비-라세미 형인 하기 일반식(Ⅰ)의 푸로[3,4-C] 피리딘 유도체 및 제약학상 허용되는 그의 염의 제조 방법.
    상기 식들 중, R3및 R3'은 독립적으로 수소 원자, 시아노기, 포화 또는 불포화된 직쇄 알킬기, 3 내지 6원 헤테로시클릭기, 3 내지 6원 시클로알킬기, 각각 하나 이상의 할로겐, 트리플루오로알킬, 저급 알킬, 저급 알콕시, 저급 티오알킬, 디알킬아미노, 디알킬아미노 알콕시 또는 α-또는 β-알콕시 N-피롤리디닐기로 치환되어도 좋은 페닐기, 페닐알킬기 또는 페닐알케닐기(단, 각 경우에 있어서 알킬 또는 알콕시 각각은 탄소수가 5개 이하임)이거나, 또는 식
    으로 나타내어지는 기(여기서, n은 2 내지 제5의 정수이고, X는 1 내지 3개의 메톡시기임)이고, R4는 수소 또는 할로겐 원자이며, R6은 하나 이상의 히드록시, 시아노, 아미노, 치환된 아미노, C1-C4알킬 또는 C1-C4알케닐로 치환되어도 좋은, 탄소수가 5개 이하인 직쇄 또는 분지쇄 저급 알킬 또는 알케닐이거나, 또는 식
    로 나타내어지는 기(여기서, n 및 X는 상기 정의 된 바와 같고, Y는 탄소수가 5개 이하인 직쇄 또는 분지쇄 저급 알킬기임)이되, 단 R3또는 R3'중 하나가 시아노이고 나머지 하나가 식
    로 나타내어지는 기일 경우, R6은
    로 나타내어지는 기가 될수 없으며, R7은 탄소수가 18개 이하인 아실기이다.
  2. 제1항에 있어서, 상기 에스테라제가 세린 프로테이나제, α-키모트립신, 트립신, 리파제, 맥아의 리파제및 돼지 췌장의 리파제로 이루어진 군 중에서 선택된 것인 방법.
  3. 제1항 또는 제2항에 있어서, 출발 물질이 상기 일반식(2)의 화합물인 방법.
  4. 제1항 또는 제2항에 있어서, 출발 물질이 상기 일반식(3)의 화합물인 방법.
  5. 제1항 내지 제4항중 어느 한 항에 있어서, R3이 P-클로로페닐이고, R3' 및 R4가 수소이고, R6이 메틸인 방법.
  6. 제1항 내지 제4항중 어느 한 항에 있어서, R3이 수소이고, R3'이 2-푸릴이며, R4가 수소이고, R6이 에틸인 방법.
  7. 제1항 내지 제4항중 어느 한 항에 있어서, R3및 R3'이 메틸이며, R4가 수소이고, R6이 프로필인 방법.
  8. 제1항 내지 제7항중 어느 한 항에 따른 방법에 의해 제조된 푸로[3,4-C] 피리딘 화합물.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019910007684A 1990-05-14 1991-05-13 비-라세미형의 푸로[3,4-c] 피리딘 유도체의 제조방법 KR910020015A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US523,238 1990-05-14
US07/523,238 US5130252A (en) 1990-05-14 1990-05-14 Resolution of furopyridine enantiomers and synthetic precursors thereof

Publications (1)

Publication Number Publication Date
KR910020015A true KR910020015A (ko) 1991-12-19

Family

ID=24084213

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019910007684A KR910020015A (ko) 1990-05-14 1991-05-13 비-라세미형의 푸로[3,4-c] 피리딘 유도체의 제조방법

Country Status (32)

Country Link
US (1) US5130252A (ko)
JP (1) JPH05117277A (ko)
KR (1) KR910020015A (ko)
AR (1) AR247762A1 (ko)
AT (1) AT400445B (ko)
AU (1) AU642368B2 (ko)
BE (1) BE1007016A3 (ko)
CA (1) CA2042421C (ko)
CH (1) CH682488A5 (ko)
DE (1) DE4115681C2 (ko)
DK (1) DK88991A (ko)
DZ (1) DZ1499A1 (ko)
ES (1) ES2033574B1 (ko)
FI (1) FI97807C (ko)
FR (1) FR2661919B1 (ko)
GB (1) GB2244056B (ko)
GR (1) GR1001593B (ko)
HK (1) HK131993A (ko)
IE (1) IE65891B1 (ko)
IT (1) IT1248743B (ko)
LU (1) LU87935A1 (ko)
MA (1) MA22154A1 (ko)
MY (1) MY107567A (ko)
NL (1) NL194615C (ko)
NO (1) NO180308C (ko)
NZ (1) NZ238009A (ko)
OA (1) OA09352A (ko)
PT (1) PT97657B (ko)
SE (1) SE510808C2 (ko)
TN (1) TNSN91035A1 (ko)
TW (1) TW226998B (ko)
ZA (1) ZA913461B (ko)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0221494D0 (en) * 2002-09-16 2002-10-23 Generics Uk Ltd Novel processes for the preparation of 1.3-dihydro-6-methylfuro (3,4-c) pyndin derivatives
US20110251396A1 (en) * 2003-07-17 2011-10-13 Gilead Sciences, Inc. Enantiomeric compositions of cicletanine, alone and in combination with other agents, for the treatment of disease
GB2419529B (en) * 2003-07-17 2008-01-09 Cotherix Inc Combination therapies for treatment of hypertension and complications in patients with diabetes or metabolic syndrome
US20060089374A1 (en) * 2003-07-17 2006-04-27 Glenn Cornett Enantiomeric compositions of cicletanine, alone and in combination with other agents, for the treatment of disease
GB2423927A (en) * 2003-08-29 2006-09-13 Cotherix Inc Combination Of Cicletanine And An Oral Antidiabetic And/Or Blood Lipid-Lowering Agent For Treating Diabetes And Metabolic Syndrome
US20060154959A1 (en) * 2005-01-13 2006-07-13 Navitas Pharma Combination therapies of cicletanine and carvedilol
EP1841436A4 (en) * 2005-01-05 2008-02-20 Medicure Int Inc COMPOUNDS AND METHOD FOR REGULATING TRIGLYCERID MIRRORS
US20080096915A1 (en) * 2005-01-13 2008-04-24 Greenberg Traurig LLP Compositions for the treatment of metabolic disorders
US20070141174A1 (en) * 2005-01-13 2007-06-21 Navitas Pharma, Inc. Enantiomeric compositions of cicletanine, in combination with other agents, for the treatment of hypertension
US20070105817A1 (en) * 2005-11-09 2007-05-10 Jim Page Use of cicletanine and other furopyridines for treatment of systolic-predominant hypertension, isolated systolic hypertension, elevated pulse pressure, and general hypertension
WO2008085872A1 (en) * 2007-01-03 2008-07-17 Cornett Glenn V Cicletanine and pkc inhibitors in the treatment of pulmonary and cardiac disorders
US8354394B2 (en) 2009-10-29 2013-01-15 Merck Sharp & Dohme Corp. Diuretics

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN156817B (ko) * 1981-02-10 1985-11-09 Scras
US4985365A (en) * 1981-11-28 1991-01-15 Sumitomo Chemical Company, Ltd. Process for producing optically active benzyl alcohol compound
DE3378834D1 (en) * 1982-08-13 1989-02-09 Kanegafuchi Chemical Ind Process for production of optically active oxazolidinone derivative
IN160104B (ko) * 1983-04-05 1987-06-27 Scras
JPS59216590A (ja) * 1983-05-24 1984-12-06 Ube Ind Ltd 光学活性フエニルプロパルギルアルコ−ル誘導体の製法
GB8327817D0 (en) * 1983-10-18 1983-11-16 Scras 4-halo-furo-(3 4-c)-pyridine derivatives
GB8330517D0 (en) * 1983-11-16 1983-12-21 Scras 6-vinyl-furo-(3,4-c)pyridine derivatives
GB8330658D0 (en) * 1983-11-17 1983-12-29 Scras 7-carboxymethoxy-furo-(3,4-c)-pyridine derivatives
GB8402740D0 (en) * 1984-02-02 1984-03-07 Scras Furo-(3 4-c)-pyridine derivatives
JPS60224494A (ja) * 1984-04-24 1985-11-08 Nissan Chem Ind Ltd α−メチルベンジルアルコ−ル類の光学分割法
GB8414559D0 (en) * 1984-06-07 1984-07-11 Scras Pyridine derivatives
GB8427218D0 (en) * 1984-10-27 1984-12-05 Scras Pyridine derivatives
JPS61289899A (ja) * 1985-06-18 1986-12-19 Kanegafuchi Chem Ind Co Ltd 光学活性２−ハロ−１−フエニルエタノ−ルおよびそのエステルの製造法
US4916074A (en) * 1986-10-30 1990-04-10 Chisso Corporation Process for producing optically active compounds
JP2691986B2 (ja) * 1987-08-28 1997-12-17 チッソ株式会社 ピリジン骨格を有する光学活性化合物の製造法
DE3737335A1 (de) * 1987-11-04 1989-05-18 Basf Ag Verfahren zur herstellung eines biokatalysators und dessen verwendung zur razematspaltung
DE3990349T1 (de) * 1988-04-06 1990-04-26 Scras Stereospezifisches verfahren zur herstellung von enantiomeren von furo(3,4-c)pyridin, so erhaltene verbindungen und therapeutische zusammensetzungen auf basis dieser verbindungen
GB8808001D0 (en) * 1988-04-06 1988-05-05 Scras Stereospecific preparative process for furol(3,4-c)pyridine derivatives
NL8801311A (nl) * 1988-05-20 1989-12-18 Stamicarbon Fenylglycidaatstereoisomeren, omzettingsprodukten daarvan met 2-nitrothiofenol en de bereiding van diltiazem.
GB8907480D0 (en) * 1989-04-03 1989-05-17 Scaras Societe De Conseils De Separation of insomers of furo(3,4-c)pyridine derivatives
GB8917168D0 (en) * 1989-07-27 1989-09-13 Scras Asymmetric synthesis of furo(3,4-c)pyridine derivatives

Also Published As

Publication number Publication date
GB2244056A (en) 1991-11-20
AU7620091A (en) 1991-11-14
DZ1499A1 (fr) 2004-09-13
SE9101431D0 (sv) 1991-05-13
FI912315A0 (fi) 1991-05-13
PT97657A (pt) 1992-02-28
SE9101431L (sv) 1991-11-15
NL9100749A (nl) 1991-12-02
ZA913461B (en) 1992-02-26
DE4115681A1 (de) 1991-11-21
TW226998B (ko) 1994-07-21
ATA98291A (de) 1995-05-15
FI97807C (fi) 1997-02-25
GB2244056B (en) 1993-08-11
US5130252A (en) 1992-07-14
LU87935A1 (fr) 1992-03-03
NL194615B (nl) 2002-05-01
CA2042421C (en) 2000-08-22
IE65891B1 (en) 1995-11-29
IT1248743B (it) 1995-01-26
PT97657B (pt) 1998-09-30
CH682488A5 (fr) 1993-09-30
NZ238009A (en) 1992-11-25
DK88991A (da) 1991-11-15
ITMI911255A0 (it) 1991-05-08
NO180308C (no) 1997-03-26
MA22154A1 (fr) 1991-12-31
CA2042421A1 (en) 1991-11-15
NO911852L (no) 1991-11-15
AR247762A1 (es) 1995-03-31
AT400445B (de) 1995-12-27
BE1007016A3 (fr) 1995-02-21
NL194615C (nl) 2002-09-03
FR2661919B1 (fr) 1994-12-30
FI97807B (fi) 1996-11-15
SE510808C2 (sv) 1999-06-28
DE4115681C2 (de) 2003-10-30
ITMI911255A1 (it) 1992-11-08
ES2033574A1 (es) 1993-03-16
OA09352A (fr) 1992-09-15
TNSN91035A1 (fr) 1992-10-25
NO180308B (no) 1996-12-16
ES2033574B1 (es) 1994-02-01
JPH05117277A (ja) 1993-05-14
AU642368B2 (en) 1993-10-14
DK88991D0 (da) 1991-05-13
FR2661919A1 (fr) 1991-11-15
GB9109810D0 (en) 1991-06-26
IE911628A1 (en) 1991-11-20
NO911852D0 (no) 1991-05-13
HK131993A (en) 1993-12-10
GR910100180A (en) 1992-07-30
GR1001593B (el) 1993-03-31
FI912315A (fi) 1991-11-15
MY107567A (en) 1996-04-30

Similar Documents

Publication Publication Date Title
PT78777A (en) Process for preparing leucine derivatives and of pharmaceutical compositions containing the same
ATE282020T1 (de) Verfahren zur herstellung von 2-aminomalonsäure- derivaten
KR910020015A (ko) 비-라세미형의 푸로[3,4-c] 피리딘 유도체의 제조방법
ATE229960T1 (de) Verfahren zur herstellung von 13-ether-derivaten von milbemycinen und zwischenprodukte
ATE215078T1 (de) Verbessertes verfahren zum herstellen von geschützten 3,4-dihydroxybuttersäure estern
DE69001732D1 (de) Verfahren zur enantioselektiven herstellung von phenylisoserin-derivaten.
ATE40570T1 (de) Verfahren zur herstellung eines optisch aktiven 3-(3,4-dihydroxyphenyl)-serins und ein geschuetztes derivat davon.
ATE138571T1 (de) Verwendung von dioxabicyclo (3.3.0>octane derivaten zur herstellung eines arzneimittels zur hemmung des cholesterinmetabolismus.
DE69728180D1 (de) Verfahren zur herstellung von carbamoylsubstituierten imidazolderivaten
DE60010243D1 (de) Verfahren und vorrichtung zur herstellung von monofonktionellen haloameisensäurearylestern
NZ222678A (en) Process for the stereospecific preparation of 2-arylpropionic acids with the aid of microorganisms
CA2078141A1 (en) Acyl phosphate esters and modification of proteins therewith
GB8606105D0 (en) Chemical compounds
DE69800073T2 (de) Verfahren zur Herstellung von 2-Cyanobiphenyl-Verbindungen
DD210709A1 (de) Verfahren zur herstellung des antibiotikums a51568 mit den faktoren a und b
DE3772703D1 (de) Verfahren zur herstellung von penemen.
DE69123009D1 (de) Verfahren zur Herstellung optisch aktiver 3-Hydroxybutan-Derivate
ATE118551T1 (de) Verfahren zur herstellung von s-2,2-r1,r2-1,3- dioxolan-4-methanol.
DE58900971D1 (de) Verfahren zur herstellung von tetralinderivaten und neue tetralinderivate.
KR880011173A (ko) 세팔로스포린 유도체의 제조방법
KR830005151A (ko) 헤테로 시클릭 화합물의 제조 방법 및 이것의 조성물
KR870010048A (ko) 아미노-티아졸 및 옥사졸 유도체의 제조방법
KR870011144A (ko) 세팔로스포린 유도체의 제조방법

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E601 Decision to refuse application